Dentium CO., LTD (KRX:145720)

Market Cap	297.83B -53.3%
Revenue (ttm)	346.45B -15.0%
Net Income	16.41B -77.4%
EPS	1,902.94 -77.4%
Shares Out	6.18M
PE Ratio	25.33
Forward PE	5.99
Dividend	600.00 (1.19%)
Ex-Dividend Date	Mar 20, 2026

Volume	39,611
Open	50,000
Previous Close	50,500
Day's Range	48,200 - 50,500
52-Week Range	43,100 - 73,400
Beta	0.63
Analysts	Strong Buy
Price Target	71,600.00 (+48.55%)
Earnings Date	May 12, 2026

About Dentium CO., LTD

Dentium CO., LTD manufactures and sells dental medical instrument worldwide. Its implant systems include superline, implantium, implantium 2, N.R. line, simple line 2, and slim line. The company also provides block and coloring; regeneration products; and digital dentistry products. In addition, it offers orthodontics, bright resin, tooth care, and other dental products. The company was formerly known as Biostech Co., Ltd. and changed its name to Dentium Co.,Ltd. in August 2002. Dentium Co.,Ltd. was founded in 2000 and is headquartered in Seoul...

• Industry: Medical Instruments & Supplies
• Sector: Healthcare
• Founded: 2000
• Employees: 853
• Stock Exchange: Korea Stock Exchange
• Ticker Symbol: 145720

Financial Performance

In 2025, Dentium CO., LTD's revenue was 346.45 billion, a decrease of -15.05% compared to the previous year's 407.81 billion. Earnings were 16.41 billion, a decrease of -77.43%.